mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
暂无分享,去创建一个
N. Sonenberg | T. Alain | O. Larsson | E. Petroulakis | R. Dowling | G. Thomas | S. Kozma | I. Topisirovic | B. Fonseca | Xiaoshan Wang | A. Selvaraj | M. Bidinosti | Yi Liu
[1] N. Sonenberg,et al. p53-dependent translational control of senescence and transformation via 4E-BPs. , 2009, Cancer cell.
[2] S. Hecht,et al. Eukaryotic initiation factor 4E binding protein family of proteins: sentinels at a translational control checkpoint in lung tumor defense. , 2009, Cancer research.
[3] C. Chresta,et al. Ku-0063794 is a specific inhibitor of the mammalian target of rapamycin (mTOR) , 2009, The Biochemical journal.
[4] D. Sabatini,et al. An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.
[5] J. Blenis,et al. Not all substrates are treated equally: Implications for mTOR, rapamycin-resistance, and cancer therapy , 2009, Cell cycle.
[6] Robbie Loewith,et al. Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2 , 2009, PLoS biology.
[7] A. Gingras,et al. Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs. , 2008, RNA.
[8] J. Graff,et al. Targeting the eukaryotic translation initiation factor 4E for cancer therapy. , 2008, Cancer research.
[9] David M Sabatini,et al. Defining the role of mTOR in cancer. , 2007, Cancer cell.
[10] N. Sonenberg,et al. Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2. , 2007, The Journal of clinical investigation.
[11] D. Sabatini. mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.
[12] G. Thomas,et al. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. , 2006, Cell metabolism.
[13] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[14] M. Murakami,et al. Distinct Signaling Events Downstream of mTOR Cooperate To Mediate the Effects of Amino Acids and Insulin on Initiation Factor 4E-Binding Proteins , 2005, Molecular and Cellular Biology.
[15] N. Sonenberg,et al. Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control , 2005, Nature Cell Biology.
[16] N. Sonenberg,et al. Upstream and downstream of mTOR. , 2004, Genes & development.
[17] J. Blenis,et al. Characterizing the interaction of the mammalian eIF4E‐related protein 4EHP with 4E‐BP1 , 2004, FEBS letters.
[18] J. Graff,et al. eIF-4E expression and its role in malignancies and metastases , 2004, Oncogene.
[19] Martin Raff,et al. Differences in the way a mammalian cell and yeast cells coordinate cell growth and cell-cycle progression , 2003, Journal of biology.
[20] P. Pandolfi,et al. Does the ribosome translate cancer? , 2003, Nature Reviews Cancer.
[21] J. Avruch,et al. Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.
[22] N. Sonenberg,et al. The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila , 2001, Nature Cell Biology.
[23] E. Hafen,et al. Drosophila S6 kinase: a regulator of cell size. , 1999, Science.
[24] S. Gygi,et al. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. , 1999, Genes & development.
[25] J. Ashby. References and Notes , 1999 .
[26] F. Hobbs,et al. Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.
[27] A. Gingras,et al. Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function , 1994, Nature.